Christopher Bhatla

Christopher Bhatla

Auto-generated profile, based on publicly available information

Christopher Bhatla

Division of Physical Medicine and Rehabilitation, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
PSPranav Shrestha
Pranav Shrestha
HLHendrik Lohse
Hendrik Lohse
CBChristopher Bhatla
Christopher Bhatla
HMHeather McCartney
Heather McCartney
AAAlaa Alzaki
Alaa Alzaki
BBBoris Boris
Boris Boris
Sickle cell disease (SCD) persists as a major global health problem, disproportionately affecting children in low- and middle-income countries (LMIC). Accurate and low-cost point-of-care techniques are urgently needed in LMIC to detect carrier or disease forms with haemoglobin S (HbS) and other variants like β-thalassemia. An open-label, international, multicentre study was conducted at clinical sites in Nepal and Canada. Blood samples were collected from healthy volunteers (HbAA) and participants with known haemoglobinopathies (HbA/β-thalassemia, HbAS, HbS/β-thalassemia, HbSS). The performance of six low-cost tests (Conventional sickling test; HbS solubility test; HemoTypeSC; Sickle SCAN; Gazelle Hb variant test; Automated sickling test using automated microscopy and machine learning) was evaluated against HPLC (ClinicalTrials.gov Identifier: NCT05506358). Between September 2022 and March 2023, we enrolled 138 participants (aged 2-74 years; 59% female, 41% male) at clinical sites in Nepal and Canada. Four low-cost tests (HemoTypeSC, Sickle SCAN, Gazelle, and automated sickling), which could identify phenotypes, detected severe SCD (HbSS, HbS/β-thalassemia) accurately (sensitivity >96%; specificity >99%). In contrast, for carrier forms, HemotypeSC and Sickle SCAN only detected HbAS (sensitivity >97%; specificity 100%) and not HbA/β-thalassemia (sensitivity 0%; specificity 100%), while Gazelle detected HbAS (sensitivity 100%, specificity 100%) and HbA/β-thalassemia (sensitivity 91%, specificity 99%), and automated sickling test detected both trait conditions (HbAS and HbA/β-thalassemia; sensitivity 85%, specificity 85%). When HbS co-exists with β-thalassemia, Gazelle and automated sickling test accurately identify severe SCD and carrier forms. However, HemotypeSC and Sickle SCAN miss β-thalassemia trait, and need to be complemented with other low-cost tests. UBCPSI, Canada Research Chairs, UBC HIFI Awards, UBC 4YF, Naiman Vickars Endowment fund.

23 June 2026 in CANADIAN PROSTHETICS & ORTHOTICS JOURNAL
Verified
Journal Article
Open access
PDF file
CBChristopher Bhatla
Christopher Bhatla
MHMatthew Ho
Matthew Ho
CDCatherine Devion
Catherine Devion
RGRun Ze Gao
Run Ze Gao
AMAmanda Lee Mayo
Amanda Lee Mayo
BACKGROUND: Additive manufacturing (3D printing) has been proposed as a means of improving customization, accessibility, and production efficiency in prosthetic fabrication. However, clinical outcomes remain incompletely characterized, with existing evidence limited by heterogeneous study designs, small samples, and inconsistent outcome reporting. OBJECTIVE: To conduct a scoping review to map the available evidence on clinical outcomes of 3D-printed prosthetic devices in individuals with limb loss or congenital limb difference. METHODOLOGY: JBI (formerly Joanna Briggs Institute) methodology and Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines were followed. MEDLINE, Embase, CINAHL, CENTRAL, and Web of Science were searched from inception to December 31, 2025. Studies were eligible if they reported clinical outcomes, assessed using an identifiable method of measurement, for a functional limb prosthesis directly fabricated using additive manufacturing. RESULTS: Of 1,396 records screened, 42 studies were included. Thirty-one (73.8%) were case reports or case series; no randomized controlled trials were identified. Thirty-two studies (76.2%) involved upper-limb prostheses and ten (23.8%) involved transtibial devices. Fused deposition modeling (FDM) was the most reported additive manufacturing method (76.2%). In upper-limb studies without a comparator, participants frequently reported improved gross motor function compared with using no prosthesis, while fine motor performance and device durability were common limitations. Where a conventional device was used as a comparator, findings were mixed rather than uniformly favoring either fabrication approach. In lower-limb studies, gait and patient-reported outcomes were generally comparable between 3D-printed and conventionally fabricated devices. CONCLUSION: The literature describes 3D-printed prostheses being fabricated, fitted, and used across a range of clinical contexts, including for customized and activity-specific designs, but the evidence base remains limited. Future work should prioritize larger comparative studies, longer follow-up, and more standardized outcome assessment to better define the role of additive manufacturing in prosthetic care. Layman's Abstract Prosthetic limbs help people who have lost a limb, or were born with a limb difference, move and carry out everyday activities. Traditionally, prostheses are manually made using techniques that take time, skill, and clinical resources. 3D printing, which builds an object layer by layer from a digital file, has been suggested as a customizable approach to prosthetic fabrication with possible workflow advantages, though it also carries its own trade-offs. It remains unclear how well 3D-printed prostheses work for the people who use them. This review searched multiple databases to identify published studies examining how people experience 3D-printed prosthetic arms or legs, including how well the devices perform, how comfortable they are, and how satisfied users feel. We identified and reviewed 42 relevant studies, most of which were small reports describing only a handful of patients rather than large trials. In arm prosthesis studies, users often reported improvements in everyday tasks compared to using no prosthesis, though fine motor performance and durability were common weaknesses; results were mixed when compared with conventionally made devices. Studies of leg prostheses generally found comparable outcomes between 3D-printed and conventional devices. Overall, the studies describe 3D-printed prostheses being made, fitted, and used in a range of clinical settings, including custom devices made for specific activities, but the evidence base remains limited. Larger, higher-quality studies with longer follow-up and more consistent outcome measures are needed to better define the role of 3D printing in the production of prostheses. Article PDF Link: https://jps.library.utoronto.ca/index.php/cpoj/article/view/47836/35342 How To Cite: Bhatla C, Ho M, Devion C, Gao R.Z, Mayo A.L. Additive manufacturing of prosthetic devices: A scoping review of clinical outcomes. Can Prosthet Orthot J. 2026;9(2):5. https://doi.org/10.33137/cpoj.v9i2.47836 Corresponding Author: Dr. Amanda L. Mayo, MD, MHSc, FRCPC, Affiliations: 1) Division of Physical Medicine and Rehabilitation, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; 2) Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.E-Mail: Amanda.Mayo@sunnybrook.ca ORCID ID: https://orcid.org/0000-0001-7061-2529

25 May 2026 in Archives of Rehabilitation Research and Clinical Translation
Verified
Journal Article
Open access
CBChristopher R. Bhatla
Christopher R. Bhatla
RRRajiv N. Reebye
Rajiv N. Reebye

23 June 2026 in CANADIAN PROSTHETICS & ORTHOTICS JOURNAL
Verified
Journal Article
Open access
PDF file
JAJan Andrysek
Jan Andrysek
AMAmanda L. Mayo
Amanda L. Mayo
CNCalvin C Ngan
Calvin C Ngan
DBDan Blocka
Dan Blocka
VPVishal Pendse
Vishal Pendse
SHSander Lorne Hitzig
Sander Lorne Hitzig
BACKGROUND: Recent advancements in digital workflows, including the use of 3D printing, are transforming the prosthetics and orthotics (P&O) field. Digital technologies offer opportunities to deliver P&O services that are more efficient by reducing design and fabrication times, are less wasteful through the elimination or reduction of consumables, including plaster, foam and other materials, and are more repeatable by having digitally saved designs. Despite known advantages, the adoption of digital workflows in P&O has been inconsistent, underscoring the need for cross-sector collaboration to guide the field using evidence-informed approaches. OBJECTIVE: To collaborate with key interest groups to identify priority areas for advancing the adoption and implementation of digital workflows in the P&O field. METHODOLOGY: A modified Delphi approach was used to inform the structure of a Canada-wide initiative and involved participation of 79 representatives from key interest groups, including prosthetists, orthotists, technicians, biomedical engineers, researchers, and people with limb absence/difference. Research priorities were identified through online surveys followed by a hybrid meeting during which attendees engaged in small- and large-group discussions to refine and select priorities. RESULTS: Five key digital P&O research priorities were identified: (1) strengthening evidence on device quality and system performance compared to traditional methods; (2) developing economic and reimbursement models to support clinical integration; (3) improving education and training for digital workflows; (4) establishing standardized practice guidelines; and (5) increasing key interest group engagement to better understand user needs and perspectives. While the general components of digital workflows are now broadly understood, future efforts should focus on more specific contexts, and discussions should be more targeted and disaggregated (e.g., by device type, patient population, or care setting) and include experts with context-specific experience. CONCLUSION: This collaboration initiative provides a strategic roadmap for advancing the adoption of digital workflows in the P&O field and supports the development of national collaborations aimed at fostering innovations and evidence-based practice. Layman's Abstract Recent advances in digital technologies, including three-dimensional (3D) printing, are changing how prostheses and orthoses are designed and fabricated. Digital workflows are the processes of using digital technologies to design and create prostheses or orthoses. These approaches may improve prostheses and orthoses care by reducing design and fabrication time, decreasing waste by reducing the use of plaster and other materials, and improving consistency by allowing designs to be digitally stored and reused. Despite these potential benefits, digital workflows are not yet widely used in clinical practice. Barriers such as limited evidence, gaps in education and training, cost and reimbursement challenges, and a lack of shared standards have slowed adoption. To help address these challenges, a Canada-wide initiative was conducted to bring together key interest groups and develop a shared research agenda. Using a structured consensus-building approach, 79 invitees (including prosthetists, orthotists, biomedical engineers, researchers, and people who use prostheses and/or orthoses) contributed through online surveys and a hybrid meeting that included group discussions. Five main research priorities were identified: generating stronger evidence comparing digitally produced prostheses or orthoses with traditionally made devices, improving education and training for digital workflows, developing economic and reimbursement models that support routine clinical use, creating baseline guidelines to promote consistent and safe practices, and increasing engagement with key interest groups to better understand their perspectives and needs. Overall, this work provides a roadmap to guide future initiatives and collaboration, supporting innovation and evidence-informed use of digital workflows in prostheses and orthoses care. Article PDF Link: https://jps.library.utoronto.ca/index.php/cpoj/article/view/46848/35280 How To Cite: Andrysek J, Mayo A.L, Ngan C.C, Blocka D, Pendse V, Calovini E, et al. Developing a research agenda in digital workflows for the fabrication of prostheses and orthoses. Can Prosthet Orthot J. 2026;9(2):4. https://doi.org/10.33137/cpoj.v9i2.46848 Corresponding Author: Prof. Jan Andrysek, PhDAffiliation: 1) Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada; 2) Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.E-Mail: JAndrysek@hollandbloorview.caORCID ID: https://orcid.org/0000-0002-4976-1228